Briacell Therapeutics Corp (BCT : TSX)
Common Stock
$4.86
CAD
+0.05 (1.04%)
Last updated: 2026-10-20
Follow BCT
BCT
Briacell Therapeutics Corp
Performance
1 Day
+1.04%
1 Week
-8.47%
1 Month
-17.77%
YTD
-50.51%
Key Statistics
Market Cap
$41.85M
52W High
$19.24
52W Low
$3.68
P/E Ratio
-
50 Day MA
$5.30
200 Day MA
$5.53
Beta
1.51
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/20/2026 | $4.78 | $5.05 | $4.77 | $4.86 | $4.86 | 4,000 |
| 10/19/2026 | $4.86 | $4.87 | $4.81 | $4.81 | $4.81 | 1,926 |
| 10/16/2026 | $5.41 | $5.41 | $4.80 | $4.88 | $4.88 | 15,457 |
| 10/15/2026 | $5.26 | $5.36 | $5.26 | $5.36 | $5.36 | 891 |
| 10/14/2026 | $5.38 | $5.50 | $5.25 | $5.25 | $5.25 | 2,967 |
| 10/13/2026 | $5.56 | $5.56 | $5.30 | $5.31 | $5.31 | 4,304 |
| 10/9/2026 | $5.56 | $5.66 | $5.56 | $5.61 | $5.61 | 1,100 |
| 10/8/2026 | $5.57 | $5.62 | $5.55 | $5.56 | $5.56 | 4,042 |
| 10/7/2026 | $5.70 | $5.73 | $5.63 | $5.69 | $5.69 | 1,723 |
| 10/6/2026 | $5.92 | $5.92 | $5.67 | $5.70 | $5.70 | 3,627 |
Analyst Price Targets
Based on analyst covering BCT · as of Sep 17, 2026
Wall Street analysts forecast BCT stock price to rise 311.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$20.00
+311.5% Upside
Current Price
C$4.86
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BCT's historical volatility
30-Day Vol
72.3%
Annualized
90-Day Vol
70.9%
Annualized
Trend (90d)
-30.0%
Annualized drift
90d Mean
C$4.37
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$4.69 | C$3.65 – C$6.02 |
| 60 trading days | C$4.52 | C$3.18 – C$6.44 |
| 90 trading days | C$4.37 | C$2.83 – C$6.72 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Briacell Therapeutics Corp
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-31.92M
- Profit Margin
- 0.00%
- ROE (TTM)
- -175.26%
- EPS (Diluted)
- -1.27
- Book Value
- 4.69
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
🔄 Recent Splits
1-for-10
Aug 25, 2025
1-for-15
Jan 29, 2025
1009-for-1000
Sep 5, 2023
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About BCT
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| AAB | Aberdeen International Inc. | $0.03 | +25.00% |
| TXP | Touchstone Exploration Inc | $0.20 | +14.71% |
| CNT | Century Global Commodities Corp | $0.04 | +14.29% |
| ELEF | Silver Elephant Mining Corp | $0.17 | +9.37% |
| XMF-A | M Split Corp | $1.80 | +9.09% |
| EPRX | Eupraxia Pharmaceuticals Inc | $10.72 | +9.05% |
| AVNT | Avant Brands Inc | $0.54 | +8.00% |
| BB | BlackBerry Ltd | $12.45 | +7.89% |
BCT.TO news timeline
15 articles covering BCT.TO, most recent first
LatestWhy Briacell Therapeutics Corp stock is sliding today
October 2026
September 2026
August 2026
- Why Briacell Therapeutics Corp stock plummeted yesterday
- Why Briacell Therapeutics Corp stock surged yesterday
- Why Briacell Therapeutics Corp stock surged yesterday
- Why Briacell Therapeutics Corp stock plummeted yesterday
- What's Going On With Briacell Therapeutics Corp Stock Monday?
- Why Briacell Therapeutics Corp stock surged yesterday